Peroxisomal Translocation of Soluble Epoxide Hydrolase Protects against Ischemic Stroke Injury
Author(s) -
Jonathan W. Nelson,
Wenri Zhang,
Nabil J. Alkayed,
Ines P. Koerner
Publication year - 2015
Publication title -
journal of cerebral blood flow and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.167
H-Index - 193
eISSN - 1559-7016
pISSN - 0271-678X
DOI - 10.1038/jcbfm.2015.159
Subject(s) - epoxide hydrolase 2 , peroxisome , stroke (engine) , cytosol , cytoplasm , chromosomal translocation , chemistry , biochemistry , microbiology and biotechnology , medicine , pharmacology , enzyme , biology , receptor , gene , mechanical engineering , engineering
Soluble epoxide hydrolase (sEH) contributes to cardiovascular disease, including stroke, although the exact mechanism remains unclear. While primarily a cytosolic enzyme, sEH can translocate into peroxisomes. The relevance of this for stroke injury is not understood. We tested the hypothesis that sEH-mediated injury is tied to the cytoplasmic localization. We found that a human sEH variant possessing increased affinity to peroxisomes reduced stroke injury in sEH-null mice, whereas infarcts were significantly larger when peroxisomal translocation of sEH was disrupted. We conclude that sEH contributes to stroke injury only when localized in the cytoplasm, while peroxisomal sEH may be protective.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom